Back to search

Article

Prevalence and Prognostic Impact of ASXL1 Somatic Mutation in Patients with Chronic Myeloid Leukemia: A Systemic Review and Meta-Analysis

2026-03-23

Abstract excerpt

<h4>Background: </h4> Outcomes in chronic myeloid leukemia (CML) remain heterogeneous despite effective BCR::ABL1 tyrosine kinase inhibitors (TKIs). Somatic mutations in epigenetic regulators, particularly additional sex combs like 1 (ASXL1), have been implicated in adverse prognosis, but their clinical impact in CML has not been systematically defined. <h4>Methods:</h4> A systematic review was conducted using CIN...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d4dc4c8e-a645-5916-b142-0a988d4a61a4
DOI
10.20944/preprints202603.1788.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prevalence and Prognostic Impact of ASXL1 Somatic Mutation in Patients with Chronic Myeloid Leukemia: A Systemic Review and Meta-AnalysisDOI 10.20944/preprints202603.1788.v1
Select a neighboring publication to make it the new centre.